1-4 of 4
Rafael Lluch-García
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First worldwide real-life data on fixed-duration ibrutinib+venetoclax treatment for previously untreated CLL/SLL patients: Updated interim analysis of Spain´s LI+VE observational study

Free
José Ángel Hernández-Rivas, Ana Muntanola Prat, Esther Sancho Ponce, Angeles Medina, Rafael Lluch-García, Ana C. De Oliveira, Alicia Rodriguez-Fernandez, Juan Alfonso Soler, Maria Jose Terol-Castera, Patricia Machado-Machado, Manuel Pérez-Encinas, Rafael Romero-Carmona, Lucrecia Yanez San Segundo, Paloma García-Martín, Clara Mompo, Elena Zubillaga-Marban
Journal: Blood
Blood (2025) 146 (Supplement 1): 2728.
https://doi.org/10.1182/blood-2025-2728
Published: 2025
Journal Articles

Implementation of 2020 international guidelines in acquired hemophilia: Insights from a decade of national registry data in Spain

Free
Maria Eva Mingot, Jose Pardos Gea, Ana Marco Rico, Mariana Canaro Hinryk, Angel Bernardo, Jose Maria Bastida, Agustín Rodriguez Alen, Faustino Garcia Candel, Dolors Tassies Penella, Ana Moreto Quintana, Gala Aglaia Menendez Navarro, Elena Rosello Palmer, Marina Carrasco Exposito, Susana Asenjo Correa, Laura Torres Miñana, Jose Antonio Rodriguez Garcia, María Teresa Alvarez-Román, Rafael Lluch Garcia, Ramon Rodriguez Gonzalez, José Manuel Martín Antorán, Nieves Alonso Escobar, Reyes Aguinaco, Maria Paz Martinez Baza, Sally Marcellini Antonio, Marisol Uribe Barrientos, Núria Fernández-Mosteirín, Sandra Valle Herrero, Carlos Cervero Santiago, Isabel Socorro Caparros Miranda, Miguel Angel Pozas Mañas, Irene Vazquez Fernandez, Maria Cristina Pascual Izquierdo, Sara Caracena Lopez, David Valcarcel, Pascual Marco VERA
Journal: Blood
Blood (2025) 146 (Supplement 1): 3077.
https://doi.org/10.1182/blood-2025-3077
Published: 2025
Journal Articles

Spanish real-life practice confirms zanubrutinib as a safe and effective option in relapsed or refractory marginal zone lymphoma: Results of a cohort of 118 patients on behalf of GELTAMO.

Free
Ana Muntanola Prat, Fernando Martin-Moro, Xabier Gutiérrez, Sofía Vázquez-Díaz, Lucía Morais, Itxaso Amarika, Ramón Diez-Feijóo, Mariana Bastos-Oreiro, Beatriz De La Cruz, Javier Marco, Sergio Ramos, Ana Jiménez Ubieto, Pablo Galindo, Juan Correa, Esperanza Lavilla-Rubira, Cristina García Herce, Miriam Moreno, Eva Domingo Domenech, Nazaret Dominguez, Aránzazu Alonso Alonso, María José Otero, Alessandra Comai, Maria Luisa Bengochea, Carolina Villegas Da Ros, Norma Gutiérrez, Rafael Lluch-García, Sara Fernandez-Luis, Joan-Alfons Soler, Jimena Cannata, Angeles Medina, Sofia Martin-Consuegra, Marta Aceituno, Paola Villafuerte Gutiérrez, Jose Maria Arguiñano, Dunia De Miguel, Javier López, Lucia Villalon Blanco, Horacio Martín, Armando Lopez-Guillermo, Antonio Salar
Journal: Blood
Blood (2025) 146 (Supplement 1): 5350.
https://doi.org/10.1182/blood-2025-5350
Published: 2025
Journal Articles

Indolent Acute Myeloid Leukemia with Long Survival in Patients Treated with Best Supportive Care Only: A Pethema Registry Study

Free
Jorge Labrador, Josefina Serrano, Laura Torres, Evelyn Acuña-Cruz, Jose A. Perez-Simon, Maria Lopez-Pavia, Gabriela Rodriguez Macias, Carmen Botella, Carlos Rodriguez, Pilar Martinez Sanchez, Maria Luz Amigo, Maria Victoria Cuevas, Teresa Bernal del Castillo, María Carmen Montes, Celina Benavente, Juan Ignacio Rodriguez-Gutierrez, Mar Tormo, Raimundo García-Boyero, Aurelio Lopez Martínez, Rafael Lluch Garcia, Jesús Lorenzo Algarra, Esperanza Lavilla, David Martinez-Cuadron, Miguel A. Sanz, Pau Montesinos
Journal: Blood
Blood (2022) 140 (Supplement 1): 8919–8920.
https://doi.org/10.1182/blood-2022-162591
Published: 2022